Clinical Trial Update: A Trial of PX-12 in Patients With a Histologically or Cytologically Confirmed Diagnosis of Advanced or Metastatic Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating PX-12 in patients with advanced or metastatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• PX-12 (PX-12)

Snippet

Sponsor: Cascadian Therapeutics Inc. | Conditions: Metastatic Cancer, Advanced Cancer | Phase 1 | Status: COMPLETED